Results of bilateral nerve sparing laparoscopic retroperitoneal lymph node dissection for testicular cancer

The Journal of Urology
Hannes SteinerReinhard Peschel

Abstract

We evaluated the feasibility and early oncological outcome of a laparoscopic nerve sparing bilateral retroperitoneal lymph node dissection. The surgical technique is described. From July 2004 to December 2007 a total of 42 patients with nonseminomatous germ cell tumor (21 with stage I, 2 with stage IIA marker negative and 19 with post-chemotherapy stage IIB disease) underwent transperitoneal bilateral laparoscopic retroperitoneal lymph node dissection. The sympathetic trunk and postganglionic nerves were identified, and lymphatic tissue was dissected between the nerves. Patients with clinical stage I and IIA disease that was lymph node positive at laparoscopic retroperitoneal lymph node dissection did not receive additional chemotherapy. Surgery was successfully completed in all patients and no conversion to open surgery was necessary. Mean operative time was 323 minutes. No intraoperative complications occurred. Of patients with stage I and marker negative stage IIA disease active tumor was found in 5 retroperitoneal lymph node dissection specimens, and no patients had recurrence. Of 19 patients with post-chemotherapy stage IIB disease teratoma was found in the lymphatic tissue in 4 (21.0%). No retroperitoneal recurrence was o...Continue Reading

References

Aug 1, 1990·The Journal of Urology·J P DonohueG Geier
Sep 1, 1995·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·J P DonohueR Bihrle
Apr 1, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D J DebonoJ P Donohue
Sep 5, 1998·The Urologic Clinics of North America·J P Donohue, R S Foster
Jul 9, 2002·Urology·Michael A PaleseLouis R Kavoussi
Mar 23, 2005·Urology·Mohamad E AllafLouis R Kavoussi
Aug 19, 2005·Current Treatment Options in Oncology·Andrew J Stephenson, Joel Sheinfeld
Jan 20, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Alexandra W van den Belt-DuseboutFlora E van Leeuwen
Oct 2, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Brett S CarverJoel Sheinfeld
Oct 2, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Alexandra W van den Belt-DuseboutFlora E van Leeuwen

❮ Previous
Next ❯

Citations

Apr 25, 2012·Der Urologe. Ausg. A·L Lusuardi, G Janetschek
Jul 16, 2010·Journal of Endourology·Alon Z Weizer, Jeffrey S Montgomery
Feb 3, 2012·Journal of Endourology·Günter Janetschek
Jun 1, 2009·Therapeutic Advances in Urology·Thomas J Guzzo, Mohamad E Allaf
Jun 11, 2010·Indian Journal of Urology : IJU : Journal of the Urological Society of India·Stephen D W Beck
Nov 3, 2011·The Urologic Clinics of North America·Tatum TarinJoel Sheinfeld
Dec 25, 2015·International Journal of Clinical Oncology·Terukazu NakamuraTsuneharu Miki
Mar 13, 2016·Current Urology Reports·Heather J ChalfinMohamad E Allaf
Oct 21, 2009·BJU International·Hannes SteinerGeorg Bartsch
Jul 29, 2010·Cancer·R Houston ThompsonJoel Sheinfeld
Jan 12, 2013·International Journal of Urology : Official Journal of the Japanese Urological Association·Yasunori KimuraTsuneharu Miki
Jul 29, 2015·The Urologic Clinics of North America·Timothy A MastersonRichard S Foster
Jul 29, 2015·The Urologic Clinics of North America·Thomas Kunit, Günter Janetschek
May 19, 2018·Journal of Endourology·Lukas LusuardiGünter Janetschek
Feb 22, 2012·Urologia·Roberto SalvioniFlavio Crippa
Jan 22, 2014·Current Opinion in Urology·Thomas Kunit, Günter Janetschek
Apr 11, 2014·The Oncologist·Stephen B RiggsDerek Raghavan
Dec 21, 2010·Expert Review of Anticancer Therapy·Michael C Risk, Richard S Foster
Feb 6, 2017·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·K Yadav

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Incidence & Mortality

Cancer has emerged as a global concern due to its increase in incidence and mortality. Efforts are underway to evaluate and develop action plans to reduce the global burden of cancer. Currently, lung cancer, breast cancer and prostate cancer are the leading causes of cancer mortality. Here is the latest research on cancer incidence and mortality.